Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Celastrol attenuates streptozotocin-induced diabetic cardiomyopathy in mice by inhibiting the ACE / Ang II / AGTR1 signaling pathway

Fig. 2

The effects of celastrol on diabetes-induced cardiac injury. (A, B) ELISA analysis of heart CK-MB and LDH expression at 16 weeks after STZ injection. (C) HE staining of heart tissue at 16 weeks after STZ injection. Magnification, 200×. Data are shown as mean ± SD. n = 6, *P < 0.05 vs. Control; # P < 0.05 vs. DCM + celastrol.

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us